Kits
Amsbio has expanded its range of Skeletal Muscle Differentiation Kits, offering researchers a reliable solution for turning pluripotent or embryonic stem cells into myoblasts with strong regenerative potential. The kit’s streamlined 3-step protocol, involving simple media changes and cell passaging, routinely produces cultures with up to 70% MF20-positive myotubes - all without the need for genetic modification or laborious cell sorting, saving both time and effort.
Designed to work with any pluripotent stem cell line, the kits deliver a uniform, physiologically competent population of skeletal muscle cells that are immediately ready for drug screening, disease modelling, and other advanced applications. For added flexibility, Amsbio can supply kits directly from stock or provide bespoke services, generating skeletal muscle myoblasts from your iPSC line of choice to fit seamlessly into any workflow, whether speed or customisation is the priority.
More information online
ILM Guide 2026/27